Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001-2002

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue SUPPL. 1, 2004, Pages

  Brown, Steven D ^a   Farrell, David J ^b  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^b GR Micro Ltd   (United Kingdom)

Author keywords

Age; RTIs; Telithromycin

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; COMMUNICABLE DISEASE; CONTROLLED STUDY; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESPIRATORY TRACT INFECTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; KETOLIDES; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIMEN HANDLING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 4444220828     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh311     Document Type: Article

References (20)

1. Musher, D. M. (2000). Streptococcus pneumoniae. In Principles and Practice of Infectious Disease, 5th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 2128-47. Churchill Livingstone, Edinburgh, UK.
2. Dever, L. L., Shashikumar, K. & Johanson, W. G. (2002). Antibiotics in the treatment of acute exacerbations of chronic bronchitis. Expert Opinion on Investigational Drugs 11, 911-25.
3. Murphy, T. F. & Sethi, S. (2002). Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient. Drugs and Aging 19, 761-75.
4. Doern, G. V. (1995). Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. American Journal of Medicine 99; 3S-7S.
5. Jacobs, M. R. (1999). Emergence of antibiotic resistance in upper and lower respiratory tract infections. American Journal of Managed Care 5, Suppl. 11, S651-61.
6. Jacobs, M. R., Bajaksouzian, S., Zilles, A. et al. (1999). Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study. Antimicrobial Agents and Chemotherapy 43, 1901-8.
7. Doern, G. V., Heilmann, K. P., Huynh, H. K. et al. (2001). Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrobial Agents and Chemotherapy 45, 1721-9.
8. Dowell, S. F., Marcy, S. M., Phillips, W. R. et al. (1998). Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 101, Suppl. 1, 163-5.
9. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Villanova, PA, USA.
10. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Sensitivity Testing - Twelfth Edition. Supplemental Tables M100-S12. NCCLS, Villanova, PA, USA.
11. National Committee for Clinical Laboratory Standards. (2004). Performance Standards for Antimicrobial Sensitivity Testing - Fourteenth Edition. Supplemental Tables M100-S14. NCCLS, Villanova, PA, USA.
12. Farrell, D. J., Morrissey, I., Bakker, S. et al. (2001). Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. Journal of Antimicrobial Chemotherapy 48, 541-4.
13. Jones, R. N., Biedenbach, D. J. & Beach, M. L. (2003). Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program. Diagnostic Microbiology and Infectious Disease 46, 77-80.
14. Karlowsky, J. A., Thornsberry, C., Jones, M. E. et al. (2003). Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clinical Infectious Diseases 36, 963-70.
15. Whitney, C. G., Farley, M. M., Hadler, J. et al. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New England Journal of Medicine 343, 1917-24.
16. Brown, S. D. & Rybak, M. J. (2004). Antimicrobial susceptibility among Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. Journal of Antimicrobial Chemotherapy 54, Suppl. S1, i7-15.
17. Shortridge, V. D., Doern, G. V., Brueggemann, A. B. et al. (1999). Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clinical Infectious Diseases 29, 1186-8.
18. Farrell, D. J. & Jenkins, S. G. (2004). Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002. Journal of Antimicrobial Chemotherapy 54, Suppl. S1, i17-22.
19. Aldridge, K. E., Daly, J. A., Harding, I. et al. (2003). Antibacterial resistance and macrolide resistance mechanisms among Streptococcus pneumoniae collected from pediatric and adult patients in the first year of PROTEKT US (2000-2001). In Program and Abstracts of the One hundred and third American Society of Microbiology General Meeting, Washington, DC, 2003. Abstract C-132. American Society of Microbiology, Washington, DC, USA.
20. Doern, G. V. & Brown, S. D. (2004). Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-2001. Journal of Infection 48, 56-65.